Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Chronic B-Cell Dyscrasias Are an Important Clinical Feature of LGL Leukemia.

Aaron D. Viny, BS, Alan Lichtin, M.D., Brad Pohlman, M.D., Zachary Nearman, B.S., Thomas Loughran, Jr., M.D., Jaroslaw P. Maciejewski, M.D./Ph.D

Blood (2007) 110 (11): 4675.

https://doi.org/10.1182/blood.V110.11.4675.4675

Published: 2007

Journal Articles

Increased Tumor Infiltrating FOXP3+ Regulatory T-Cells Are Associated with Improved Survival in Classical Hodgkin Lymphoma.

Todd W. Kelley, MD, Brad Pohlman, M.D., Paul Elson, Sc.D., Eric D. Hsi, M.D.

Blood (2006) 108 (11): 2265.

https://doi.org/10.1182/blood.V108.11.2265.2265

Published: 2006

Journal Articles

Improved Outcomes with Class I and II DNA-Based HLA Typing for Matched Unrelated Donor (MUD) Allogeneic Bone Marrow Transplant (ABMT) in Hematologic Diseases.

Ronald Sobecks, M.D., Edward J. Ball, PhD, Lisa Rybicki, Elizabeth Kuczkowski, Matt Kalaycio, M.D., Brad Pohlman, M.D., Steven Andresen, D.O., Karen Sands, R.N., Jennifer Kosar, R.N., Mary Serafin, R.N., Jennifer Bates, Christy Lalli, Brian Bolwell, M.D.

Blood (2004) 104 (11): 5181.

https://doi.org/10.1182/blood.V104.11.5181.5181

Published: 2004

Journal Articles

Outcomes Analysis of Patients Surviving ≥2 Years after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, M.D., Matt Kalaycio, M.D., Brad Pohlman, M.D., Steven Andresen, D.O., Lisa Rybicki, Jennifer Kosar, R.N., Mary Serafin, R.N., Karen Sands, R.N., Christy Lalli, Stacey Brown, Elizabeth Kuczkowski, Brian Bolwell, M.D.

Blood (2004) 104 (11): 2762.

https://doi.org/10.1182/blood.V104.11.2762.2762

Published: 2004

Journal Articles

MAL Is Expressed in a Subset of Hodgkin Lymphomas and Identifies a Population of Patients with Poor Prognosis.

Eric D. Hsi, M.D., Stephen J. Sup, M.D., Carlos Alemany, M.D., Elisa Tso, M.D., Marek Skacel, M.D., Paul Elson, Sc.D., Miguel A. Alonso, Ph.D., Brad Pohlman, M.D.

Blood (2004) 104 (11): 3117.

https://doi.org/10.1182/blood.V104.11.3117.3117

Published: 2004

Journal Articles

Increased Risk of Non-Relapse Mortality within One Year after Autologous Stem Cell Transplant in Older Adults with Lymphoma.

Matt Kalaycio, M.D., Brad Pohlman, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Kristie Summers, Brian J. Bolwell, M.D., Lisa Rybicki, Elizabeth Kuckowski

Blood (2004) 104 (11): 5111.

https://doi.org/10.1182/blood.V104.11.5111.5111

Published: 2004

Journal Articles

High Incidence of Extramedullary Relapses Following Allogeneic Bone Marrow Transplant (Allo-BMT) in Adults with Acute Lymphoblastic Leukemia.

Ahmed Absi, M.D., Brian J. Bolwell, M.D., Ronald Sobecks, M.D., Brad Pohlman, M.D., Steve Andresen, D.O., Lisa Rybicki, Matt Kalaycio, M.D.

Blood (2004) 104 (11): 5117.

https://doi.org/10.1182/blood.V104.11.5117.5117

Published: 2004

Journal Articles

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

Brian J. Bolwell, M.D., Elizabeth Kuczkowski, Lisa Rybicki, Brad Pohlman, M.D., Steven Andresen, D.O., Ronald Sobecks, M.D., Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Alison Vellani, Nicole Berry, Shawnda Sungren, Leslie Foster, Matt Kalaycio, M.D.

Blood (2004) 104 (11): 4993.

https://doi.org/10.1182/blood.V104.11.4993.4993

Published: 2004

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Stacey Brown, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 1880.

https://doi.org/10.1182/blood.V104.11.1880.1880

Published: 2004

Journal Articles

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Brian J. Bolwell, M.D., Brad Pohlman, M.D., Steve Andresen, D.O., Sheila Serafino, Ronald Sobecks, M.D., Elizabeth Kuczkowski, Julie Curtis, R.N., Lisa Rybicki, Jarek Maciejewski, M.D., PhD, Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Matt Kalaycio, M.D., Eric Hsi, M.D., Karl Theil, M.D.

Blood (2004) 104 (11): 443.

https://doi.org/10.1182/blood.V104.11.443.443

Published: 2004

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Jennifer Bates, Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 896.

https://doi.org/10.1182/blood.V104.11.896.896

Published: 2004

Journal Articles

Psychosocial Factors in Decision-Making of Patient Eligibility for Allogeneic Bone Marrow Transplantation.

Brian J. Bolwell, M.D., Linda McLellan, LISW, Elizabeth Kuczkowski, Jane Dabney, LISW, Victoria Wentling, Brad Pohlman, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Matt Kalaycio, M.D., Bridget Rini, Julie Curtis, R.N., Larry W. Foster, PhD, Mikkael A. Sekeres, M.D., M.S.

Blood (2004) 104 (11): 3324.

https://doi.org/10.1182/blood.V104.11.3324.3324

Published: 2004

Journal Articles

Autologous Transplantation for Diffuse Large B Cell Lymphoma: Pre-Transplant Hypogammaglobulinemia Is a Predictor for Early Toxicities.

Brian J. Bolwell, M.D., Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Lisa Rybicki, Elizabeth Kuczkowski, Jennifer Bates, Kristie Summers, Laura Bernhard, Kelly Cherni, Janet Baker, Stacey Brown, Brad Pohlman, M.D.

Blood (2004) 104 (11): 908.

https://doi.org/10.1182/blood.V104.11.908.908

Published: 2004

NARROW

Chronic B-Cell Dyscrasias Are an Important Clinical Feature of LGL Leukemia.

Increased Tumor Infiltrating FOXP3+ Regulatory T-Cells Are Associated with Improved Survival in Classical Hodgkin Lymphoma.

Improved Outcomes with Class I and II DNA-Based HLA Typing for Matched Unrelated Donor (MUD) Allogeneic Bone Marrow Transplant (ABMT) in Hematologic Diseases.

Outcomes Analysis of Patients Surviving ≥2 Years after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

MAL Is Expressed in a Subset of Hodgkin Lymphomas and Identifies a Population of Patients with Poor Prognosis.

Increased Risk of Non-Relapse Mortality within One Year after Autologous Stem Cell Transplant in Older Adults with Lymphoma.

High Incidence of Extramedullary Relapses Following Allogeneic Bone Marrow Transplant (Allo-BMT) in Adults with Acute Lymphoblastic Leukemia.

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

Psychosocial Factors in Decision-Making of Patient Eligibility for Allogeneic Bone Marrow Transplantation.

Autologous Transplantation for Diffuse Large B Cell Lymphoma: Pre-Transplant Hypogammaglobulinemia Is a Predictor for Early Toxicities.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only